0.37 +0.00 (0.00%)
NLTX
Stock Details
Last Trade:0.37 Change:+0.00 (0.00%) Prev Close:0.37 Open: 0.36 Days Range:0.35 – 0.37 52 Week Range: 0.29 - 2.30 Volume:16200 P/E: N/AEPS:-0.31
View AllRecent Alerts 07/31/10
Recent Alert on 07/07/10 at 7:41am
Nile Therapeutics (NLTX) Completes Dosing in CD-NP Phase II
Nile Therapeutics (NLTX) Completes Dosing in CD-NP Phase II
Nile Therapeutics, Inc. (Nasdaq: NLTX) today announced that it has completed the dosing of the last patient in NIL-CDNP-CT005, an open-label, single-blind, placebo-controlled Phase II study of CD-NP in patients with acute decompensated heart... Read More
Recent Alert on 05/14/10 at 7:10am
Nile Therapeutics, Inc (NLTX) Posts Q1 Loss of $0.07, Misses Views
Nile Therapeutics, Inc (NLTX) Posts Q1 Loss of $0.07, Misses Views
Recent Alert on 05/10/10 at 11:01am
Nile Therapeutics (NLTX) Announces Exercise of Over-Allotment Option by Underwriters in Recent Offering
Nile Therapeutics (NLTX) Announces Exercise of Over-Allotment Option by Underwriters in Recent Offering
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
SEC Filing on 07/28/10 at 5:12pm
Form 4 Nile Therapeutics, Inc. For: Jul 26 Filed by: Kazam Joshua A
Form 4 Nile Therapeutics, Inc. For: Jul 26 Filed by: Kazam Joshua A
SEC Filing on 07/28/10 at 5:11pm
Form 4 Nile Therapeutics, Inc. For: Jul 26 Filed by: GRANADILLO PEDRO P
Form 4 Nile Therapeutics, Inc. For: Jul 26 Filed by: GRANADILLO PEDRO P
SEC Filing on 07/28/10 at 5:10pm
Form 4 Nile Therapeutics, Inc. For: Jul 26 Filed by: Belldegrun Arie
Form 4 Nile Therapeutics, Inc. For: Jul 26 Filed by: Belldegrun Arie